Social Responsibility

In the tangled corridors of government oversight, Dr. Jeffrey E. Shuren was a prominent figure, heading the Food and Drug Administration’s medical device branch for more than a decade. Leading a team of about 2,500 people, Dr. Shuren oversaw an expansive budget of about $790 million, according to U.S. Senate Health, Education, Labor, and Pensions Committee documents. Dr. Shuren’s tenure has been marked by significant accomplishments, including record approvals of innovative medical devices ranging from joint replacements to infectious disease diagnostics. His leadership was recently praised by FDA Commissioner Dr. Robert Califf, who highlighted the historic number of new device…

In a recent long-term research study published Tuesday, Eli Lilly reported that its popular weight-management drug significantly reduced the incidence of type 2 diabetes by 94 percent among overweight or obese adults who had prediabetic symptoms, compared to a control group that received a placebo. The late-stage study explored the effects of tirzepatide, the active compound in both Eli Lilly’s Zepbound weight-loss shot and the diabetes treatment Mounjaro. Over about three years, participants who received the highest weekly dose of tirzepatide experienced an average reduction in body weight of 22.9 percent, while those who took a placebo saw only a…

An Airbus A321 neo operated by Wizz Air Malta was recently spotted at Eindhoven Airport, performing maneuvers such as taxiing, take-off and flight in a pristine blue sky. LONDON — European travelers have another reason to celebrate, as Wizz Air has unveiled an annual membership that costs just €499 ($550), allowing for unlimited flights. This introductory offer, set to increase to €599 after Friday, gives cardholders the freedom to schedule one-way and return flights throughout the year. According to the airline's official website, this "unlimited" pass allows bookings for all international destinations Wizz Air offers, such as Athens, Madrid, Paris…

Estee Lauder Chairman and CEO Fabrizio Freda will retire, marking the end of an impactful era for the cosmetics giant. Estee Lauder forecast its annual sales and profits will fall short of expectations as the global beauty industry faces declining demand, particularly in China. The announcement comes amid news that CEO Fabrizio Freda, who has led the company since 2009, will step down on June 30, 2025, ending nearly 16 years of leadership. During her tenure, Freda, 66, has significantly expanded Estee Lauder’s skin care line, incorporating popular brands like Dr. Jart and Deciem, which owns The Ordinary. She has…